Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
105.30
-0.70 (-0.66%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Haemonetics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Haemonetics stock has a consensus rating of "Buy" and an average price target of $111.5. The average 1-year stock price forecast is 5.89% higher than the current stock price, while the lowest is $86 (-18.33%) and the highest is $125 (+18.71%).
Price Target: $111.5 (+5.89%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Haemonetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Upgrades $92 → $123 | Buy | Upgrades | $92 → $123 | +16.81% | Sep 17, 2026 |
| Raymond James | Raymond James | Buy Maintains $105 → $125 | Buy | Maintains | $105 → $125 | +18.71% | Sep 3, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $96 → $119 | Buy | Maintains | $96 → $119 | +13.01% | Aug 21, 2026 |
| Barrington | Barrington | Buy Maintains $95 → $118 | Buy | Maintains | $95 → $118 | +12.06% | Aug 19, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 18, 2026 |
Financial Forecast
Revenue This Year
1.42B
from 1.33B
Increased by 6.21%
Revenue Next Year
1.50B
from 1.42B
Increased by 5.54%
EPS This Year
5.31
from 4.96
Increased by 7.04%
EPS Next Year
5.78
from 5.31
Increased by 8.81%
EPS and Forward PE are based on non-GAAP adjusted numbers.